BizCommunity - 25 Oct 2022
Access to vital HIV prevention could lead to lower infection rates in at-risk populations
Decades of diligent research lies behind the new availability of pre-exposure prophylaxis (PrEP) against HIV for communities in Cape Town, says Elsevier, a global information and analytics leader.
In a new series of articles showcasing how credible research changes lives, Elsevier highlights the Desmond Tutu Health Foundation (DTHF), which is making HIV prophylaxis easily accessible to at-risk communities in the Klipfontein-Mitchells Plain, large health district in the metro of Cape Town.
The DTHF, along with its affiliated Desmond Tutu HIV Centre, is an accredited research organisation within the Faculty of Health Sciences, University of Cape Town, and has been working with communities to lessen the impact of HIV since the 1990s.
Where antiretrovirals (ARVs) dramatically improved patient outcomes and life expectancy in the early 2000s, pre-exposure prophylaxis (PrEP) in the form of pills, long-acting injectables or implants now promise to help prevent people from ever contracting HIV.
Read more:
